Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DYRK3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF2D - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MAPKAPK2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RASSF5 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IL10 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IKBKE - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IL19 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IL20 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IL24 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
FCMR - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SRGAP2C - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on